Switch to:
Also traded in: Canada, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt No Debt
BUR's Cash to Debt is ranked higher than
93% of the 935 Companies
in the Global Biotechnology industry.

( Industry Median: 58.56 vs. BUR: No Debt )
Ranked among companies with meaningful Cash to Debt only.
BUR' s Cash to Debt Range Over the Past 10 Years
Min: N/A  Med: 10000.00 Max: No Debt
Current: No Debt

Warning: Division by zero in /home/gurufocu/public_html/include/common_stock_functions_2.php on line 6679
N/A
No Debt
Equity to Asset 0.85
BUR's Equity to Asset is ranked higher than
76% of the 707 Companies
in the Global Biotechnology industry.

( Industry Median: 0.69 vs. BUR: 0.85 )
Ranked among companies with meaningful Equity to Asset only.
BUR' s Equity to Asset Range Over the Past 10 Years
Min: 0.84  Med: 0.90 Max: 0.94
Current: 0.85
0.84
0.94
F-Score: 4
Z-Score: 123.95
M-Score: -3.94
WACC vs ROIC
14.70%
-354.49%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -6368.22
BUR's Operating margin (%) is ranked lower than
91% of the 730 Companies
in the Global Biotechnology industry.

( Industry Median: -77.71 vs. BUR: -6368.22 )
Ranked among companies with meaningful Operating margin (%) only.
BUR' s Operating margin (%) Range Over the Past 10 Years
Min: -18770  Med: -6582.11 Max: -6560.95
Current: -6368.22
-18770
-6560.95
Net-margin (%) -6140.19
BUR's Net-margin (%) is ranked lower than
91% of the 730 Companies
in the Global Biotechnology industry.

( Industry Median: -78.92 vs. BUR: -6140.19 )
Ranked among companies with meaningful Net-margin (%) only.
BUR' s Net-margin (%) Range Over the Past 10 Years
Min: -18486.67  Med: -6275.79 Max: -6265.71
Current: -6140.19
-18486.67
-6265.71
ROE (%) -112.82
BUR's ROE (%) is ranked lower than
84% of the 857 Companies
in the Global Biotechnology industry.

( Industry Median: -32.89 vs. BUR: -112.82 )
Ranked among companies with meaningful ROE (%) only.
BUR' s ROE (%) Range Over the Past 10 Years
Min: -130.08  Med: -64.62 Max: -53.49
Current: -112.82
-130.08
-53.49
ROA (%) -101.34
BUR's ROA (%) is ranked lower than
88% of the 939 Companies
in the Global Biotechnology industry.

( Industry Median: -28.03 vs. BUR: -101.34 )
Ranked among companies with meaningful ROA (%) only.
BUR' s ROA (%) Range Over the Past 10 Years
Min: -111.29  Med: -61.63 Max: -48.16
Current: -101.34
-111.29
-48.16
ROC (Joel Greenblatt) (%) -1176.61
BUR's ROC (Joel Greenblatt) (%) is ranked lower than
63% of the 902 Companies
in the Global Biotechnology industry.

( Industry Median: -360.35 vs. BUR: -1176.61 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
BUR' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -1207.15  Med: -923.80 Max: -271.69
Current: -1176.61
-1207.15
-271.69
EBITDA Growth (3Y)(%) -6.30
BUR's EBITDA Growth (3Y)(%) is ranked lower than
54% of the 498 Companies
in the Global Biotechnology industry.

( Industry Median: -2.20 vs. BUR: -6.30 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
BUR' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -16.3  Med: 1.10 Max: 260.4
Current: -6.3
-16.3
260.4
EPS Growth (3Y)(%) 0.30
BUR's EPS Growth (3Y)(%) is ranked higher than
55% of the 492 Companies
in the Global Biotechnology industry.

( Industry Median: -5.10 vs. BUR: 0.30 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
BUR' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -18.2  Med: -0.75 Max: 325
Current: 0.3
-18.2
325
» BUR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

BUR Guru Trades in

Q2 2014

BUR Guru Trades in Q2 2014

Chuck Royce 433,253 sh (+3.18%)
» More
Q3 2014

BUR Guru Trades in Q3 2014

Chuck Royce 419,903 sh (-3.08%)
» More
Q4 2014

BUR Guru Trades in Q4 2014

Chuck Royce Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with BUR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Biotechnology » Biotechnology
Compare:NAS:TRIL, NAS:NVLS, OTCPK:HSDT, NAS:AKAO, NAS:QLTI, OTCPK:COTQF, NAS:TENX, NAS:LIFE, OTCPK:MCUJF, NAS:SBPH, NAS:CAPR, NAS:REPH, NAS:ONS, NAS:PIRS, NAS:CFRX, NAS:DRNA, NAS:CHMA, NAS:XOMA, OTCPK:AMEUF, OTCPK:INNMF » details
Traded in other countries:BU.Canada, BNE.Germany,
Burcon NutraScience Corp and its subsidiary are research and development companies that are developing plant protein extraction and purification technology in the field of functional, renewable plant proteins.

Burcon NutraScience Corp was incorporated on November 3, 1998. The Company, through its subsidiary, Burcon NutraScience (MB) Corp. is a research and development company building a portfolio of composition, application and process patents around its plant protein extraction and purification technology. The Company's products include CLARISOY, a soy protein isolate, which is used in various food products, including protein shakes, power bars, soups and sauces, meats and meat analogs, and breads and baked foods; and PEAZAZZ, a soluble pea protein isolate. Its products also comprise canola protein isolates, such as Supertein that comprises albumin proteins used in beverages, confectionery, aerated desserts, and protein bars; Puratein, which consists of globulin proteins used in dressings and sauces, meat substitutes, baked goods, and protein bars.

Ratios

vs
industry
vs
history
P/B 23.64
BUR's P/B is ranked lower than
95% of the 1075 Companies
in the Global Biotechnology industry.

( Industry Median: 3.25 vs. BUR: 23.64 )
Ranked among companies with meaningful P/B only.
BUR' s P/B Range Over the Past 10 Years
Min: 7.93  Med: 15.00 Max: 37.26
Current: 23.64
7.93
37.26
P/S 679.55
BUR's P/S is ranked lower than
95% of the 838 Companies
in the Global Biotechnology industry.

( Industry Median: 12.77 vs. BUR: 679.55 )
Ranked among companies with meaningful P/S only.
BUR' s P/S Range Over the Past 10 Years
Min: 462.5  Med: 780.00 Max: 3560
Current: 679.55
462.5
3560
Current Ratio 11.01
BUR's Current Ratio is ranked higher than
79% of the 908 Companies
in the Global Biotechnology industry.

( Industry Median: 4.51 vs. BUR: 11.01 )
Ranked among companies with meaningful Current Ratio only.
BUR' s Current Ratio Range Over the Past 10 Years
Min: 1.38  Med: 10.90 Max: 55.01
Current: 11.01
1.38
55.01
Quick Ratio 11.01
BUR's Quick Ratio is ranked higher than
79% of the 908 Companies
in the Global Biotechnology industry.

( Industry Median: 4.24 vs. BUR: 11.01 )
Ranked among companies with meaningful Quick Ratio only.
BUR' s Quick Ratio Range Over the Past 10 Years
Min: 1.38  Med: 10.90 Max: 55.01
Current: 11.01
1.38
55.01
Days Sales Outstanding 518.50
BUR's Days Sales Outstanding is ranked lower than
98% of the 607 Companies
in the Global Biotechnology industry.

( Industry Median: 62.37 vs. BUR: 518.50 )
Ranked among companies with meaningful Days Sales Outstanding only.
BUR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 425.83  Med: 507.52 Max: 541.74
Current: 518.5
425.83
541.74

Valuation & Return

vs
industry
vs
history
Price/Net Cash 51.75
BUR's Price/Net Cash is ranked lower than
89% of the 739 Companies
in the Global Biotechnology industry.

( Industry Median: 5.19 vs. BUR: 51.75 )
Ranked among companies with meaningful Price/Net Cash only.
BUR' s Price/Net Cash Range Over the Past 10 Years
Min: 2.63  Med: 21.67 Max: 202
Current: 51.75
2.63
202
Price/Net Current Asset Value 41.40
BUR's Price/Net Current Asset Value is ranked lower than
90% of the 871 Companies
in the Global Biotechnology industry.

( Industry Median: 4.83 vs. BUR: 41.40 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
BUR' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 2.58  Med: 19.98 Max: 134.67
Current: 41.4
2.58
134.67
Price/Tangible Book 34.50
BUR's Price/Tangible Book is ranked lower than
95% of the 1012 Companies
in the Global Biotechnology industry.

( Industry Median: 4.22 vs. BUR: 34.50 )
Ranked among companies with meaningful Price/Tangible Book only.
BUR' s Price/Tangible Book Range Over the Past 10 Years
Min: 2.43  Med: 13.52 Max: 57.14
Current: 34.5
2.43
57.14
Price/Median PS Value 0.87
BUR's Price/Median PS Value is ranked higher than
61% of the 769 Companies
in the Global Biotechnology industry.

( Industry Median: 0.96 vs. BUR: 0.87 )
Ranked among companies with meaningful Price/Median PS Value only.
BUR' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.66  Med: 1.02 Max: 3.87
Current: 0.87
0.66
3.87
Earnings Yield (Greenblatt) (%) -6.68
BUR's Earnings Yield (Greenblatt) (%) is ranked higher than
56% of the 1169 Companies
in the Global Biotechnology industry.

( Industry Median: -9.30 vs. BUR: -6.68 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
BUR' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -11.1  Med: 0.00 Max: 0
Current: -6.68
-11.1
0

More Statistics

Revenue (TTM) (Mil) $0.08
EPS (TTM) $ -0.14
Beta0.74
Short Percentage of Float0.11%
52-Week Range $1.22 - 3.99
Shares Outstanding (Mil)35.83

Analyst Estimate


Warning: Invalid argument supplied for foreach() in /home/gurufocu/public_html/modules/stock/estimate.php on line 163
Mar17 Mar18 Mar19
Revenue (Mil $) 2 7 16
EPS ($) -0.09 0.03 0.22
EPS w/o NRI ($) -0.09 0.03 0.22
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for BUR

Headlines

Articles On GuruFocus.com
Burelle: A Growing Euro for 50 cents Mar 12 2013 

More From Other Websites
Burcon NutraScience Corp. :BUR-US: Earnings Analysis: Q4, 2016 By the Numbers : July 8, 2016 Jul 08 2016
Burcon reports 4Q loss Jun 27 2016
Burcon reports 4Q loss Jun 27 2016
BURCON ANNOUNCES FISCAL 2016 RESULTS AND REVIEWS OPERATIONS Jun 27 2016
Burcon Announces Fiscal 2016 Results and Reviews Operations Jun 27 2016
Burcon Announces Issuance of Convertible Note May 12 2016
Burcon NutraScience Corp.: BURCON ANNOUNCES CONVERTIBLE NOTE FINANCING Apr 08 2016
BURCON ANNOUNCES CONVERTIBLE NOTE FINANCING Apr 07 2016
Burcon NutraScience Corp. :BUR-US: Earnings Analysis: Q3, 2016 By the Numbers Apr 07 2016
Burcon Nutrascience (BUR) Jumps: Stock Moves Up 26.2% Feb 18 2016
Burcon reports 3Q loss Feb 12 2016
Burcon reports 3Q loss Feb 12 2016
Sysco Corporation (SYY) in Focus: Stock Moves 8.4% Higher Feb 02 2016
BURCON ANNOUNCES NEW DIRECTOR Jan 28 2016
BURCON UPDATES ON CLARISOY™ COMMERCIALIZATION PROGRESS Dec 17 2015
Burcon NutraScience Corp. Earnings Analysis: Q2, 2016 By the Numbers Dec 16 2015
BURCON NUTRASCIENCE CORP Financials Dec 08 2015
BURCON TO PRESENT AT THE 2015 CIBC AGRICULTURE CONFERENCE Nov 04 2015
Burcon NutraScience Corp. Earnings Q1, 2016 Oct 02 2015
Burcon reports 1Q loss Aug 14 2015
Burcon reports 1Q loss Aug 14 2015
Burcon reports 4Q loss Jun 23 2015
Burcon reports 4Q loss Jun 23 2015
Burcon reports 3Q loss Feb 17 2015
Burcon reports 3Q loss Feb 17 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)